specif adopt immunotherapi tumor-drain lymph node cell lymph node LN tumor tumor-sensit function preeffector lymphocyt cell therapeut efficaci sequenti cultur mab day incub day weakli immunogen mca mca murin sarcoma condit activ preeffector cell immun effector cell vitro activ expans effector cell sequenti independ stimul simultan presenc stage efficaci activ gener effector cell two-stag activ depend optim concentr microgram/ml u/ml condit optim cellular prolifer adopt immunotherapi experi transfer cell regress metastas concomit administr vivo activ cell tumor regress cell specif specif tumor preeffector cell respons spite vivo antitumor effect tumor-drain LN cell detect vitro cytotox tumor target assay mice bear progress tumor LN preeffector cell preeffector cell spleen wherea mesenter LN reactiv kinet studi sensit preeffector cell drain LN day tumor inocul tumor presenc preeffector cell tumor-induc suppress result condit tumor-drain LN cell absenc tumor Ag specif therapeut effector cell find possibl similar approach immun effector cell cancer patient adopt immunotherapi 